Portolan Capital Management, LLC Pfizer Inc Transaction History

Portolan Capital Management, LLC

  • $1.26 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$31.75 - $37.25 $4.96 Million - $5.82 Million
-156,310 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$30.12 - $36.54 $2.79 Million - $3.38 Million
-92,529 Reduced 37.18%
156,310 $5.11 Million
Q1 2020

May 14, 2020
BUY
$27.03 - $38.62 $6.73 Million - $9.61 Million
248,839 New
248,839 $8.12 Million

Others Institutions Holding PFE

# of Institutions
3,258
Shares Held
3.62B
Call Options Held
77.2M
Put Options Held
122M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $143B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Portolan Capital Management, LLC Portfolio

Follow Portolan Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portolan Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portolan Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email